Research study Program year 2024 Source: CMS Open Payments

Tagrisso Testing Tx Patterns RWO early stage NSCLC

Research payments

$148,253

7 payments

Through program year 2024, $148,253 in research payments was reported against Tagrisso Testing Tx Patterns RWO early stage NSCLC, across 7 payments, paid by AstraZeneca UK Limited.

Paid by: AstraZeneca UK Limited
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$59,774	4
2023	Research	$88,479	3

Breakdown

Who paid Research payments · program years 2023–2024

AstraZeneca UK Limited $148,253 7 payments

Who received the money Research payments · program years 2023–2024

Ut Md Anderson Cancer Center Teaching hospital · TX $104,843 2 payments
Balmiki, Rajeev, Office Organisation paid for research $18,900 1 payment
Northeast Georgia Medical Center Teaching hospital · GA $13,000 2 payments
Stanford Univ Organisation paid for research $10,010 1 payment
Bd Of Trustees Of The Leland Stanfo Organisation paid for research $1,500 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.